Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

May 21, 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

News Conference News EuroPCR 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

Yael L. Maxwell

May 16, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

May 15, 2024

Debate Continues on TAVI Choice for Women With Small Annuli

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

May 19, 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

May 16, 2023

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

May 27, 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

May 18, 2022

Good TAVI Results Seen Bicuspid Aortic Stenosis TVT Registry.PNG

News Conference News EuroPCR 2021

Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry

May 20, 2021

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

May 24, 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PA RTNER S3 Studies

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.